Drug interactions involving cimetidine--mechanisms, documentation, implications.

W Greene
{"title":"Drug interactions involving cimetidine--mechanisms, documentation, implications.","authors":"W Greene","doi":"10.1515/dmdi.1984.5.1.25","DOIUrl":null,"url":null,"abstract":"<p><p>In summary, cimetidine is a potent inhibitor of liver microsomal activity, which may also decrease hepatic blood flow. Other effects of the drug include inhibition of gastric secretion and intrinsic toxic properties. These effects, combined with the common use of cimetidine in clinical practice, make the risk of adverse drug interactions a relatively frequent risk in the clinical setting. Although a multitude of interactions with cimetidine has been evaluated, many of these are incompletely described or understood. At the present time, a potentially significant alteration of absorption appears to exist with only ketoconazole, elemental iron, vitamin B12 (long-term therapy), and pancreatic enzyme supplements (increased activity). Significant metabolic inhibition or decreased excretion appears to exist with warfarin, propranolol, theophylline, phenytoin, quinidine, possibly lidocaine and procainamide, and certain benzodiazepines. Other potential, but less well ascertained interactions may involve the narcotic analgesics, caffeine, ethanol, pentobarbital, imipramine, chlormethiazole, and metronidazole. In these settings, the clinician must be aware of interaction potential, and astutely monitor the patient during combination therapy. Other data indicate that concomitant administration of antacids may reduce the absorption of cimetidine, that the drug may protect against the toxic effects of acetaminophen overdose, and that combination with certain other myelosuppressants may carry a significant risk. Thus, in regard to these reports, cimetidine is a drug with complex effects on the absorption, elimination, and toxicity of other drugs. When used in the setting of multiple drug therapy, the clinician must be alert to potentially increased or decreased effects of the drugs mentioned in this review. In addition, one must be aware that other hepatically metabolised agents not mentioned here may be affected by the addition of cimetidine therapy. Because of the therapeutic successes demonstrated in the treatment of various disorders with cimetidine, one cannot disregard this agent. Thus, the responsibility for understanding and monitoring for the complex effects of this drug falls with the practicing physician.</p>","PeriodicalId":79248,"journal":{"name":"Quarterly reviews on drug metabolism and drug interactions","volume":"5 1","pages":"25-51"},"PeriodicalIF":0.0000,"publicationDate":"1984-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1515/dmdi.1984.5.1.25","citationCount":"19","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Quarterly reviews on drug metabolism and drug interactions","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1515/dmdi.1984.5.1.25","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 19

Abstract

In summary, cimetidine is a potent inhibitor of liver microsomal activity, which may also decrease hepatic blood flow. Other effects of the drug include inhibition of gastric secretion and intrinsic toxic properties. These effects, combined with the common use of cimetidine in clinical practice, make the risk of adverse drug interactions a relatively frequent risk in the clinical setting. Although a multitude of interactions with cimetidine has been evaluated, many of these are incompletely described or understood. At the present time, a potentially significant alteration of absorption appears to exist with only ketoconazole, elemental iron, vitamin B12 (long-term therapy), and pancreatic enzyme supplements (increased activity). Significant metabolic inhibition or decreased excretion appears to exist with warfarin, propranolol, theophylline, phenytoin, quinidine, possibly lidocaine and procainamide, and certain benzodiazepines. Other potential, but less well ascertained interactions may involve the narcotic analgesics, caffeine, ethanol, pentobarbital, imipramine, chlormethiazole, and metronidazole. In these settings, the clinician must be aware of interaction potential, and astutely monitor the patient during combination therapy. Other data indicate that concomitant administration of antacids may reduce the absorption of cimetidine, that the drug may protect against the toxic effects of acetaminophen overdose, and that combination with certain other myelosuppressants may carry a significant risk. Thus, in regard to these reports, cimetidine is a drug with complex effects on the absorption, elimination, and toxicity of other drugs. When used in the setting of multiple drug therapy, the clinician must be alert to potentially increased or decreased effects of the drugs mentioned in this review. In addition, one must be aware that other hepatically metabolised agents not mentioned here may be affected by the addition of cimetidine therapy. Because of the therapeutic successes demonstrated in the treatment of various disorders with cimetidine, one cannot disregard this agent. Thus, the responsibility for understanding and monitoring for the complex effects of this drug falls with the practicing physician.

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
涉及西咪替丁的药物相互作用——机制、文献、影响。
总之,西咪替丁是一种有效的肝微粒体活性抑制剂,它也可能减少肝血流。该药的其他作用包括抑制胃分泌和内在毒性。这些影响,加上临床实践中西咪替丁的普遍使用,使得药物不良相互作用的风险在临床环境中相对频繁。虽然已经评估了与西咪替丁的多种相互作用,但其中许多相互作用尚未完全描述或理解。目前,似乎只有酮康唑、铁元素、维生素B12(长期治疗)和胰酶补充剂(活性增加)对吸收有潜在的显著改变。华法林、心得安、茶碱、苯妥英、奎尼丁、可能还有利多卡因和普鲁卡因酰胺以及某些苯二氮卓类药物似乎存在明显的代谢抑制或排泄减少。其他潜在但不太确定的相互作用可能涉及麻醉性镇痛药、咖啡因、乙醇、戊巴比妥、丙咪嗪、氯甲咪唑和甲硝唑。在这些情况下,临床医生必须意识到相互作用的可能性,并在联合治疗期间敏锐地监测患者。其他数据表明,同时服用抗酸剂可能会减少西咪替丁的吸收,该药物可能会防止对乙酰氨基酚过量的毒性作用,并且与某些其他骨髓抑制剂合用可能会带来重大风险。因此,就这些报告而言,西咪替丁是一种对其他药物的吸收、消除和毒性具有复杂影响的药物。当用于多种药物治疗时,临床医生必须警惕本综述中提到的药物可能增加或减少的作用。此外,必须注意的是,这里没有提到的其他肝脏代谢药物可能会受到西咪替丁治疗的影响。由于用西咪替丁治疗各种疾病的治疗成功,人们不能忽视这种药物。因此,了解和监测这种药物的复杂影响的责任落在执业医师身上。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
自引率
0.00%
发文量
0
期刊最新文献
Drug interactions involving cimetidine--mechanisms, documentation, implications. Metabolism and pharmacokinetics of hydroxyethylated rutosides in animals and man. Hepatic drug metabolism in pregnancy. Drug-pyridoxal phosphate interactions. Specific covalent binding and toxicity of aliphatic halogenated xenobiotics.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1